Human cell coding company using OPTi-OX reprogramming technology.
Founders
Mark Kotter(Canada · ♂)— A Cambridge neurosurgeon and stem cell biologist, Kotter spun his opti-ox cell-coding technology out of the university in 2016 (as Elpis Biomed, later bit.bio) to reliably reprogram stem cells into defined human cell types at scale.
Team & hubs
Members see the full profile
Create a free EquityFlow account to see bit.bio's 1 funding round, 4 investors, 12 similar companies.